The swab and viral transport medium market is expected to grow at a CAGR of around 3% from 2020 to 2027 and expected to reach the market value of around US$ 900 Mn by 2027.
Swab and viral transport medium focuses on collection, storage, maintenance, and transportation of the clinical samples. This contains chlamydia, viruses, and urea, plasma organisms, and mycoplasma organisms. The viral skin swab is gently spread in the visible skin vesicles or lesions and then transmitted to the laboratories in a viral transport medium for virus identification and virus cell culture.
Growth Factors
The global corona virus has fuel the demand for swab and viral transport mediums. The remarkable amount of diagnostic tests of corona virus and surging cases of COVID patients worldwide, is accompanies the demand for the swab and viral transport medium market. During the SARS-CoV-2 pandemic, state public health laboratories authorized very country and city laboratories in each state to perform testing. This resulted in high demand for testing kits or diagnostic kits for testing. Such high demand for performing the test resulting in surging number of COVID patients propel the demand for global swab and viral transport medium market in the forecast period. Rising number of small-sized emerging manufacturers boosts the business activities such as number of policies & initiatives that was undertaken by the government for COVID-19 affected countries, resulting in high utilization of testing kits in the pandemic situation. Such factors further stimulate the growth of global swab and viral transport medium market in the forecast period. Companies like BIO-MED launched virus sample collection and transport kit specially designed transport system to collect samples from throat or nasal secretion and transport viruses in an active form to the laboratory for isolation/identification. It is specifically designed to maintain the viability and the virulence of the viral sample. Bio-Med virus transport medium (BM-VTM) kit is specially designed for collection and transportation of clinical specimens containing viruses. Additionally, pricing expenditure and initiatives by various organizations globally towards the management of COVID-19 offers lucrative opportunities for the expansion of global swab and viral transport medium market in the forthcoming years. PrimeStore MTM (Molecular Transport Medium) was designed and optimized for molecular testing allowing pathogenic samples to be collected, transported, and processed safely and efficiently. Millions of PrimeStore MTM has been sold to clients worldwide during the SARS-CoV-2 pandemic. PrimeStore MTM is the only cleared FDA Class 2 cleared product for microbial nucleic acid storage and stabilization, hospitals, and laboratories as safer and reliable testing as compared to UTM/VTM, saline, or research use only devices. Rising government initiatives or involvement fuels the growth of the market. Surging demand for COVID-19 diagnostic had a strong impact on the production of swabs, reagents, and sterile containers. As per the release of Questex LLC, currently FDA has loosened its oversight of viral transport media, the liquid solution that keeps samples viable till test performed in labs. Majority of the molecular and antigen based diagnostic test granted emergency authorization require some form of viral transport media or different types of sterile saline solution. FDA is allowing commercial manufacturers to ship their products without prior notification of trial for new medical device. Such factors contribute to the fullest for growth of swab and viral transport medium market.
Segmental Outlook
The swab and viral transport medium market is based on the product type, indication, an end-user. By product type, the market is sub-segmented into viral transport medium and virus swabs. The viral transport medium is further bifurcated as glycerol transport medium and tissue culture medium. Virus swabs is further segregated as deep nasal swabs, culture swabs, nasopharyngeal swabs, combined nasal & throat swabs, and vaginal swabs. Based on indication, the market is categorized as mumps virus, influenza, varicella-zoster virus, rhinovirus, respiratory syncytial virus, adenovirus, herpes simplex virus, COVID-19, and other indications. By end-user, the market is segmented as diagnostic laboratories, microbiology laboratories, hospitals & clinics, and others.
Regional Overview
North America is expected to record largest market share for the swab and viral transport medium market. Surging amount of diagnostic tests and presence of major market players in this region positively impact the growth of regional market. The requirement for the swab and viral transport medium have raise the demand during COVID-19, labs & research institute are having a strong focus on the experimentation for developing corona virus vaccine. Prominent players in the swab and viral transport medium have improved their manufacturing capabilities and developing innovative products that can prove useful for viral culture, collection, and maintenance. For instance, LaunchWorks CDMO, a contract development and manufacturing company serving the life science market, has received approval from the FDA for manufacturing and distribution of Viral Transport Media (VTM), in accordance with Section IV.B of the FDA’s COVID-19 Transport Media Policy. The company's vial transport media is available in the form of bulk tubes, large volume containers, and a specimen kit, that involves a tube of sterile LaunchWorks VTM, a biohazard bag and an absorbent bag.
On the other hand, Asia Pacific is expected to gain a significant pace in the global market for swab and viral transport medium market in the coming years. One of the prominent factors that is responsible for the growth of APAC regional market is surging demand of specimen collection kits in APAC region. In-vitro diagnostic test are performed on samples taken from the human body such as swabs and mucus inside the nose or back of the throat, or blood taken from a vein or finger stick. Beyond tests that diagnose or detect SARS-CoV-2 virus or antibodies, there are also tests that are authorized for use in the management of COVID-19. These involve detection of biomarkers related to inflammation. Once patients are diagnosed with COVID-19 disease, this additional test can be used to inform patient management decisions. Such diagnostic tests kits in APAC region further fuels the growth of regional market for swab and viral transport medium.
Competitive Landscape
The global swab and transport medium market is highly fragmented with the presence of numerous companies operating locally, regionally, as well as in international market. Companies in the global swab and viral transport medium market are continuously increasing their accessibility of ready-to-use and sterile swabs for testing of COVID-19. A number of companies have been competing in the global market for swab and viral transport medium. These involve Medical Wire & Equipment (MWE), BTNX, YOCON Biology, DiaSorin Molecular LLC, VIRCELL S.L., COPAN Diagnostics, HiMedia Laboratories, Thermo Fisher Scientific, Becton Dickinson and Company, Hardy Diagnostics, Titan Biotech Ltd., Puritan Medical Products, Deltalab and among others.
Market Segmentation
Market By Product Type
Viral Transport Medium
- Glycerol Transport Medium
- Tissue Culture Medium
Virus Swabs
- Deep Nasal Swabs
- Culture Swabs
- Nasopharyngeal Swabs
- Combined Nasal & Throat Swabs
- Vaginal Swabs
Market By Indication
Mumps Virus
Influenza
Varicella-Zoster Virus
Rhinovirus
Respiratory Syncytial Virus
Adenovirus
Herpes Simplex Virus
Covid-19
Others
Market By End-User
Diagnostic Laboratories
Microbiology Laboratories
Hospitals & Clinics
Others
Market By Geography
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Swab and Viral Transport Medium
1.1. Definition and Scope
1.1.1. Definition of Swab and Viral Transport Medium
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Swab and Viral Transport Medium Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Swab and Viral Transport Medium Market By Product Type
1.2.3. Swab and Viral Transport Medium Market By Indication
1.2.4. Swab and Viral Transport Medium Market By End-User
1.2.5. Swab and Viral Transport Medium Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Swab and Viral Transport Medium Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Swab and Viral Transport Medium Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2. R&D Status and Application Source of Swab and Viral Transport Medium Major Manufacturers in 2019
CHAPTER 5. Swab and Viral Transport Medium Market By Product Type
5.1. Introduction
5.2. Swab and Viral Transport Medium Revenue By Product Type
5.2.1. Swab and Viral Transport Medium Revenue (US$ Mn) and Forecast, By Product Type, 2016-2027
5.2.2. Viral Transport Medium
5.2.2.1. Viral Transport Medium Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.2. Glycerol Transport Medium
5.2.2.2.1. Glycerol Transport Medium Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.3. Tissue Culture Medium
5.2.2.3.1. Tissue Culture Medium Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Virus Swabs
5.2.3.1. Virus Swabs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3.2. Deep Nasal Swabs
5.2.3.2.1. Deep Nasal Swabs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3.3. Culture Swabs
5.2.3.3.1. Culture Swabs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3.4. Nasopharyngeal Swabs
5.2.3.4.1. Nasopharyngeal Swabs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3.5. Combined Nasal & Throat Swabs
5.2.3.5.1. Combined Nasal & Throat Swabs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3.6. Vaginal Swabs
5.2.3.6.1. Vaginal Swabs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Swab and Viral Transport Medium Market Revenue By Indication
6.1. Introduction
6.2. Swab and Viral Transport Medium Revenue (US$ Mn) By Indication
6.2.1. Swab and Viral Transport Medium Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
6.2.2. Mumps virus
6.2.2.1. Mumps virus Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Influenza
6.2.3.1. Influenza Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Varicella-zoster virus
6.2.4.1. Varicella-zoster virus Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Rhinovirus
6.2.5.1. Rhinovirus Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.6. Respiratory Syncytial Virus
6.2.6.1. Respiratory Syncytial Virus Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.7. Adenovirus
6.2.7.1. Adenovirus Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.8. Herpes Simplex Virus
6.2.8.1. Herpes Simplex Virus Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.9. COVID-19
6.2.9.1. COVID-19 Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.10. Others
6.2.10.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. Swab and Viral Transport Medium Market By End-User
7.1. Introduction
7.2. Swab and Viral Transport Medium Revenue (US$ Mn) By End-User
7.2.1. Swab and Viral Transport Medium Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027
7.2.2. Diagnostic Laboratories
7.2.2.1. Diagnostic Laboratories Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.3. Microbiology Laboratories
7.2.3.1. Microbiology Laboratories Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.4. Hospitals & Clinics
7.2.4.1. Hospitals & Clinics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.5. Others
7.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 8. North America Swab and Viral Transport Medium Market By Country
8.1. North America Swab and Viral Transport Medium Overview
8.2. U.S.
8.2.1. U.S. Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
8.2.2. U.S. Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
8.2.3. U.S. Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027
8.3. Canada
8.3.1. Canada Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
8.3.2. Canada Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
8.3.3. Canada Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027
8.4. North America PEST Analysis
CHAPTER 9. Europe Swab and Viral Transport Medium Market By Country
9.1. Europe Swab and Viral Transport Medium Market Overview
9.2. U.K.
9.2.1. U.K. Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
9.2.2. U.K. Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
9.2.3. U.K. Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027
9.3. Germany
9.3.1. Germany Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
9.3.2. Germany Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
9.3.3. Germany Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027
9.4. France
9.4.1. France Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
9.4.2. France Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
9.4.3. France Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027
9.5. Spain
9.5.1. Spain Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
9.5.2. Spain Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
9.5.3. Spain Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
9.6.2. Rest of Europe Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
9.6.3. Rest of Europe Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Swab and Viral Transport Medium Market By Country
10.1. Asia Pacific Swab and Viral Transport Medium Market Overview
10.2. China
10.2.1. China Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.2.2. China Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
10.2.3. China Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027
10.3. Japan
10.3.1. Japan Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.3.2. Japan Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
10.3.3. Japan Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027
10.4. India
10.4.1. India Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.4.2. India Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
10.4.3. India Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027
10.5. Australia
10.5.1. Australia Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.5.2. Australia Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
10.5.3. Australia Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027
10.6. South Korea
10.6.1. South Korea Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.6.2. South Korea Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
10.6.3. South Korea Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.7.2. Rest of Asia-Pacific Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
10.7.3. Rest of Asia-Pacific Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Swab and Viral Transport Medium Market By Country
11.1. Latin America Swab and Viral Transport Medium Market Overview
11.2. Brazil
11.2.1. Brazil Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
11.2.2. Brazil Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
11.2.3. Brazil Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027
11.3. Mexico
11.3.1. Mexico Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
11.3.2. Mexico Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
11.3.3. Mexico Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
11.4.2. Rest of Latin America Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Indication, 2016 – 2027
11.4.3. Rest of Latin America Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027
CHAPTER 12. Middle East & Africa Swab and Viral Transport Medium Market By Country
12.1. Middle East & Africa Swab and Viral Transport Medium Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
12.2.2. Saudi Arabia Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
12.2.3. Saudi Arabia Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027
12.3. UAE
12.3.1. UAE Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
12.3.2. UAE Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
12.3.3. UAE Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
12.4.2. Rest of Middle East & Africa Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
12.4.3. Rest of Middle East & Africa Swab and Viral Transport Medium Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027
CHAPTER 13. Player Analysis Of Swab and Viral Transport Medium
13.1. Swab and Viral Transport Medium Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Swab and Viral Transport Medium Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. COMPANY PROFILE
14.1. Medical Wire & Equipment (MWE)
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. Medical Wire & Equipment (MWE) 2019 Swab and Viral Transport Medium Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. BTNX
14.3. YOCON Biology
14.4. DiaSorin Molecular LLC
14.5. VIRCELL S.L.
14.6. COPAN Diagnostics
14.7. HiMedia Laboratories
14.8. Thermo Fisher Scientific
14.9. Becton Dickinson and Company
14.10. Hardy Diagnostics
14.11. Titan Biotech Ltd.
14.12. Puritan Medical Products
14.13. Deltalab
14.14. Others
